HPLC-DAD-ESI-MS/MS Characterization of Bioactive Secondary Metabolites from Strelitzia nicolai Leaf Extracts and Their Antioxidant and Anticancer Activities In vitro
1, 1, 1, 1, 2
- 1Departments of Medicinal Chemistry, Theodor Bilharz Research Institute, Giza, EGYPT.
- 2Departments of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza, EGYPT.
CORRESPONDENCE
Mosad Ghareeb
Departments of Medicinal Chemistry, Theodor Bilharz Research Institute, Giza, EGYPT.
Volume 10, Issue 4 · pp. 368-378 · 2018 · DOI: 10.4103/pr.pr_89_18
ABSTRACT
Background: Strelitzia nicolai Regel and Körn (Strelitziaceae) is native to Southern Africa whose phytochemistry and pharmacology were slightly investigated.Materials and Methods: In the current work, different solvent extracts of S. nicolai were screened for their chemical profiles through high‑performance liquid chromatography coupled with diode array detection and electrospray ionization mass spectrometry (HPLC‑DAD‑ESI‑MS/MS) analyses. Furthermore, their in vitro antioxidant, cytotoxic, and anticancer activities were evaluated using 2,2’‑diphenyl‑1‑picrylhydrazyl radical (DPPH), 2,2’‑azino‑bis (3‑ethylbenzothiazoline‑6‑sulphonic acid) (ABTS) & ferric reducing antioxidant power (FRAP) and crystal violet staining (CVS) colorimetric assays, respectively.Results: HPLC‑DAD‑ESI‑MS/MS analyses led to the identification of nineteen and eleven phenolic compounds from the ethyl acetate and n‑butanol extracts, respectively including flavonoids (e.g., quercetin 3‑(2 G‑rhamnosylrutinoside, quercetin, quercetin‑3‑O‑glucoside, kaempferol‑3,7‑O‑dirhamnoside, isorhamnetin‑3‑O‑rutinoside and kaempferol‑3‑O‑glucoside), phenolic acids derivatives (e.g., chlorogenic acid glycoside, protocatechuic acid‑O‑glucoside and caftaric acid ), chalcones (e.g., xanthoangelol), and phenylethanoids (e.g., ligstroside glucoside). Moreover, in the DPPH assay the IC50 value of the most active ethyl acetate extract was 20.49 μg/mL, relative to 2.92 μg/mL of ascorbic acid. ABTS and FRAP results reinforced the results of DPPH assay. According to the National Cancer Institute criteria, the tested extracts showed weak to moderate cytotoxic activities with IC50 values ranged from 65.23 to 451.29 μg/ mL. Furthermore, the EtOAc and n‑BuOH extracts showed a noticeable anticancer activity with CVS spectroscopic readings for liver hepatocellular carcinoma growth 0.806 and 0.684 at a concentration (125 μg/mL), as well as 0.730 and 0.618 at concentration (500 μg/mL), respectively against control at 1.022.Conclusion: The obtained results reveal the high efficacy of the phenolic‑rich extracts from S. nicolai as naturally occurring antioxidant and anti‑tumor agents.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Ghareeb, M., Saad, A., Ahmed, W., Refahy, L., & Nasr, S. (2018). HPLC-DAD-ESI-MS/MS Characterization of Bioactive Secondary Metabolites from Strelitzia nicolai Leaf Extracts and Their Antioxidant and Anticancer Activities In vitro. Pharmacognosy Research, 10(4), 368-378. https://doi.org/10.4103/pr.pr_89_18
Copyright and licence
© 2018 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0